Gossamer Bio Inc (NASDAQ: GOSS) is 56.71% higher on its value in year-to-date trading and has touched a low of $0.45 and a high of $1.88 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The GOSS stock was last observed hovering at around $1.40 in the last trading session, with the day’s gains setting it 0.03%.
Currently trading at $1.43, the stock is 12.01% and 37.27% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.43 million and changing 2.14% at the moment leaves the stock 41.37% off its SMA200. GOSS registered 2.14% gain for a year compared to 6-month loss of 50.65%. The firm has a 200-day simple moving average (SMA200) of -$1.47.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 62.50% gain in the last 1 month and extending the period to 3 months gives it a 37.50%, and is -5.30% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 10.09% over the week and 11.86% over the month.
Gossamer Bio Inc (GOSS) has around 135 employees, a market worth around $322.58M and $0.00M in sales. Distance from 52-week low is 216.02% and -23.94% from its 52-week high. The company has generated returns on investments over the last 12 months (-69.08%).
Gossamer Bio Inc quarterly earnings per share for the current quarter are estimated at -$0.18.The EPS is expected to grow by 35.70% this year
114 institutions hold shares in Gossamer Bio Inc (GOSS), with institutional investors hold 95.48% of the company’s shares. The shares outstanding are 225.41M, and float is at 188.82M with Short Float at 7.57%. Institutions hold 93.30% of the Float.
The top institutional shareholder in the company is HHLR Advisors, LTD with over 4.97 million shares valued at $5.97 million. The investor’s holdings represent 2.21% of the GOSS Shares outstanding. As of Jun 29, 2023, the second largest holder is Millennium Management Llc with 4.21 million shares valued at $5.05 million to account for 1.87% of the shares outstanding. The other top investors are Octagon Capital Advisors LP which holds 3.96 million shares representing 1.76% and valued at over $4.75 million, while Vanguard Group Inc holds 1.59% of the shares totaling 3.58 million with a market value of $4.3 million.
Gossamer Bio Inc (GOSS) Insider Activity
The most recent transaction is an insider purchase by Milligan Sandra, the company’s Director. SEC filings show that Milligan Sandra bought 32,000 shares of the company’s common stock on Nov 15 ’23 at a price of $0.79 per share for a total of $25213.0. Following the purchase, the insider now owns 32000.0 shares.
Gossamer Bio Inc disclosed in a document filed with the SEC on Nov 13 ’23 that Giraudo Bryan (COO/CFO) bought a total of 200,000 shares of the company’s common stock. The trade occurred on Nov 13 ’23 and was made at $0.56 per share for $0.11 million. Following the transaction, the insider now directly holds 0.38 million shares of the GOSS stock.
Still, SEC filings show that on Jun 22 ’23, Aranda Richard (Chief Medical Officer) disposed off 1,814 shares at an average price of $1.29 for $2340.0. The insider now directly holds 197,574 shares of Gossamer Bio Inc (GOSS).
